Skip to content
  • 公司动态
  • 加入我们

ZH-CN EN

logo
  • 关于我们
  • 解决方案
  • 专注领域
  • 产品
  • 联系我们
  • Search
Search this website
Menu Close
Search this website
  • 关于我们
  • 解决方案
  • 专注领域
  • 产品
  • 联系我们
  • Search
  • 公司动态
  • 加入我们

ZH-CN EN

News & Updates 2

  1. Home>
  2. cn>
  3. News & Updates 2

公司动态

    • 首页 >公司动态
神经技术

全球神经技术市场

年龄分布

中国神经科技市场

资源

行业新闻和外部资源

资源

内部资源

神经技术

全球神经技术市场

全球神经技术市场

神经技术领域(NeuroTech)是现代生物技术中最有前景和潜力的领域之一。 神经技术使用电刺激和传感作为分析和控制神经系统功能的工具,用于研究、诊断和治疗。 在区域比例上,美国在行业中处于绝对领先地位,占企业总数的53.6%。 欧洲是第二大市场,占据了 20.3% 的份额。亚洲公司仅占 5.7%,但在过去几年中,神经技术在亚洲地区一直在大幅增长,尤其是在中国。 神经技术市场的最大部分目前是神经调节,其次是神经假体和神经传感。 下图显示了 2013 年至 2024 年的全球神经调节市场规模。

https://www.statista.com/statistics/731881/neurostimulation-devices-total-market-worldwide/

目前科学家对大脑实际工作方式的理解仍然有限,这使得以有效和可重复的方式与更优秀的神经系统整合的设备的开发变得复杂。 在过去十年中,七个国际参与者发起了“大脑计划”,包括美国、欧洲、日本、中国和以色列的实体。 这些大脑计划涉及来自政府、学术界、军队和工业界的利益相关者,并将数亿美元用于特定的研究目标。 这些举措的成果不仅会加深我们对大脑的理解,还会促进新技术的发展,这些新技术将对患者的生命、公共卫生甚至国家安全产生深远的影响。

尽管过去几年神经科学取得了令人瞩目的成就,但由于神经系统运作的高内在风险,以及昂贵的研发成本,只有基于新颖的高前景技术的杰出初创公司才能进入大众市场。神经技术行业还严重依赖于私人和公共健康保险是否愿意报销设备成本。神经技术市场既有老牌竞争对手,也有初创公司, 神经技术的主要竞争对手包括 Medtronic、Boston Scientific、Abbott、LivaNova、Nevro、Blackrock 和 Advanced Bionics。

年龄分布

中国神经科技市场

中国神经科技市场

中国日益老龄化的人口导致老年痴呆症和其他神经系统疾病的发病率和流行率不断上升。 下图显示了 2011 年至 2021 年中国人口的年龄分布,这突出了65岁以上年龄组人口的增长。 据估计,目前中国14亿人口中约有五分之一患有慢性神经精神疾病或神经退行性疾病。 老年人护理所需的资源和服务将给国家的福利计划和医疗系统带来巨大压力,在最近的五年计划中,解决人口老龄化带来的经济和生产力问题被提上首要议程。

https://www.statista.com/statistics/731881/neurostimulation-devices-total-market-worldwide/

中国拥有世界最大的脑部疾病患者人口,迫切需要早期诊断和新型干预技术。 对于神经设备制造商而言,中国是一个重要的、快速增长的市场。 2016 年 3 月,中国全国人民代表大会批准了为期15年的中国大脑项目。它是为期至2030年的科技创新计划的四个试点项目之一。中国脑计划以脑认知神经原理研究为基础,形成“一体两翼”的结构,旨在开发重大脑疾病的治疗方法,推动新一代人工智能的发展。 中国脑计划主要关注三种神经和精神疾病:儿童自闭症、成人抑郁症和老年人阿尔茨海默症。

在中国,政府投资的资金流向全国专门的大脑研究机构或大学。 中国大脑研究的一些顶级中心是清华大学、天津大学、浙江大学、上海神经科学研究所和北京中国大脑研究所。 中国的深部脑刺激和其他神经调节设备制造商,在过去十年中发展迅猛。 PINS Medical 和 SceneRay 是该领域的主要中国竞争对手。

资源

行业新闻和外部资源

行业新闻和外部资源

2022 年全球神经调节设备市场研究报告

到2029年,市场规模达95.6亿美元——在中枢神经系统药物的低批准率的环境下,神经调节作为附加疗法崭露头角。

shorturl.at/lxIQ0

迷走神经双重神经调控对2型糖尿病模型代谢的影响

研究发现,在 2 型糖尿病猪模型中,对肝纤维进行高频交流电阻滞同时使用刺激迷走神经,可降低葡萄糖变异性。

https://finance.yahoo.com/news/reshape-lifesciences-presents-data-proprietary-123000529.html

深部脑刺激对严重强迫症有效

深部脑刺激可将强迫症的症状改善高达 50%,并使三分之二的患者得到实质性改善。

https://neurosciencenews.com/dbs-ocd-21460/

刺激迷走神经加强胃和大脑之间的交流

迷走神经的非侵入性刺激可以在几分钟内帮助加强胃和大脑之间的交流。

https://finance.yahoo.com/news/reshape-lifesciences-presents-data-proprietary-123000529.html

对与奖励和动机相关的大脑区域进行深部脑刺激是治疗抑郁症的潜在方法

深部脑刺激应用于与奖赏和动机相关的小脑区,导致植入后 12 个月的大脑代谢发生变化,并减轻对药物有抵抗性的抑郁症患者的一些抑郁症状。

https://neurosciencenews.com/depression-dbs-21273/

资源

内部资源

内部资源

宣传册

下载

footer_logo_new

关于我们

  • 关于我们
  • 为什么选择 MaxNova
  • 领导团队
  • 战略投资

解决方案

  • 伙伴关系
  • 本地化
  • 商业化

专注领域

  • 神经系统健康
  • 神经系统疾病
  • 治疗和疗法
  • 当前需求
  • 神经技术的发展

产品

  • 开放式创新
  • 产品组合

公司

  • 联系我们
  • 公司动态
  • 加入我们
关于我们
  • 关于我们
  • 为什么选择 MaxNova
  • 领导团队
  • 战略投资
解决方案
  • 伙伴关系
  • 本地化
  • 商业化
专注领域
  • 神经系统健康
  • 神经系统疾病
  • 治疗和疗法
  • 当前需求
  • 神经技术的发展
产品
  • 开放式创新
  • 产品组合
公司
  • 联系我们
  • 公司动态
  • 加入我们
© 2025 MaxNova 保留所有权利
  • 隐私政策
1

Louis Wang

Chief Executive Officer

About Louis

Louis is a visionary entrepreneur in the medical device industry with over 25 years of expertise. He and his team have played a crucial role in the growth of Televia into a well-known brand in China, where they have worked closely with reputable medical manufacturers such as Drager, Siemens, Maquet, Carestream, and Pentax for the past two decades. Louis’s deep understanding of the industry enables him and his team to implement their Open Innovation strategy and bring their innovative medical devices to China and other emerging markets. Louis holds an MBA from the University of Chicago Booth School of Business.

Skills and Specialties

visionary entrepreneur

Education

MBA

The University of Chicago Booth School of Business

Bachelor of Electronic Engineering

Xi’an Technological University

Language

Chinese

English

1

Louis Wang

首席执行官


关于Louis

Louis 是医疗器械行业一位富有远见的企业家,拥有超过 25 年的专业知识和经验。 他和他的团队在 Televia 成长为中国知名品牌的过程中发挥了至关重要的作用。在过去的二十年里,他们与 Drager、Siemens、Maquet、Carestream 和 Pentax 等知名医疗制造商密切合作。 Louis 对该行业的深刻理解使他和他的团队能够进行开放式创新,并将创新医疗设备推向中国和其他新兴市场。 Louis 拥有芝加哥大学布斯商学院的工商管理硕士学位。

技能和专长

有远见的企业家

教育背景

MBA

The University of Chicago Booth School of Business

Bachelor of Electronic Engineering

Xi’an Technological University

语言

Chinese

English

14

Jason Gu

Startup, USA


About Jason

Jason is an entrepreneur with a Ph.D. in materials science and an MBA from the University of Chicago Booth School of Business. He is also a Stanford-certified project manager and has extensive experience working with VC firms and selling companies.

Skills and Specialties

entrepreneur

Education

Ph.D. in materials science

MBA

University of Chicago Booth School of Business

Language

Chinese

English

14

Jason Gu

美国创业公司顾问


关于Jason

Jason 是一位拥有材料科学博士学位的企业家,并在芝加哥大学布斯商学院获得工商管理硕士学位。他还是斯坦福大学认证的项目经理,在风险投资公司及公司出售方面拥有丰富的经验。

技能和专长

企业家

教育背景

Ph.D. in materials science

MBA

University of Chicago Booth School of Business

语言

Chinese

English

10

Alina Zhang

亚洲战略投资


关于Alina

张晓婉女士侧重于公司医疗健康行业的成长型股权投资、以及收购兼并投资。张女士拥有18年在中国和其他亚洲地区投资的经验,投资领域涉及多个行业,包括医疗健康、消费、零售、TMT等,在企业战略投资规划、财务规划、风险投资和私募股权基金运营方面拥有丰富的经验。张女士拥有英国伦敦城市大学CASS商学院的金融硕士学位和中南财经政法大学经济学学士学位。

技能和专长

基金运作

风险投资/私募股权

教育背景

Master of Science in Finance

Cass Business School, City University of London

Bachelor’s Degree in Economics

Zhongnan University of Economics and Law

语言

Chinese

English

10

Alina Zhang

Strategic Investment, Asia


About Alina

Alina Zhang has a wealth of experience in growth investment, mergers and acquisitions, and venture capital/private equity fund operations. Ms. Zhang has been investing in China and other Asian markets for 18 years, with extensive experience across a wide range of industries, including healthcare, consumer, retail, technology, media, and telecom, as well as has many years of experience in strategic investment planning, financial planning, and venture capital fund / private equity fund operations. Ms. Zhang received her Master of Science in Finance from Cass Business School, City University of London, and a bachelor’s degree in Economics from Zhongnan University of Economics and Law.

Skills and Specialties

Fund Operations

VC/PE

Education

Master of Science in Finance

Cass Business School, City University of London

Bachelor’s Degree in Economics

Zhongnan University of Economics and Law

Language

Chinese

English

12

Alexander Wallstein

Global Operations


About Alexander

Chief Executive Officer at Quasar. Alex Wallstein has many years of senior management experience in the medical device industry, including positions at Johnson & Johnson and Medtronic in Minneapolis and Shanghai. Alex received a BS in Medical Computer Science from Ruprecht-Karls-University in Heidelberg, a Master of Engineering from Eidgenössische Technische Hochschule (ETH) Zürich, and an MBA from the University of Chicago.

Skills and Specialties

Chief Executive Officer

Education

MBA

University of Chicago

BS in Medical Computer Science

Ruprecht-Karls-University in Heidelberg

Master of Engineering

Eidgenössische Technische Hochschule (ETH) Zürich

Language

English

German

12

Alexander Wallstein

全球运营


关于Alexander

Quasar 首席执行官。 Alex Wallstein 在医疗器械行业拥有多年的高级管理经验,包括在明尼阿波利斯和上海的强生公司和美敦力公司任职。 Alex 在海德堡的 Ruprecht-Karls-University 获得医学计算机科学学士学位,在 Eidgenössische Technische Hochschule (ETH) Zürich 获得工程硕士学位,在芝加哥大学获得 MBA 学位。

技能和专长

首席执行官

教育背景

MBA

University of Chicago

BS in Medical Computer Science

Ruprecht-Karls-University in Heidelberg

Master of Engineering

Eidgenössische Technische Hochschule (ETH) Zürich

语言

English

German

6

Daniel Zhou

Chief Operational Officer


About Daniel

With ten years of experience in China’s medical technology industry, Daniel helps overseas MedTech/biotech startups enter the Asian market and raise funds from Chinese investors. He is the business advisor of the Office of Technology Commercialization, University of Minnesota. Daniel holds an MBA from Bar-Ilan University, Israel.

Skills and Specialties

Business Advisor

Technology Commercialization

Education

MBA

Bar-Ilan University, Israel

Language

Chinese

English

Spanish

6

Daniel Zhou

技术商业化顾问


关于Daniel

凭借在中国医疗科技行业十年的经验,Daniel 帮助海外医疗科技/生物科技初创公司进入亚洲市场并受到中国投资者青睐。他是明尼苏达大学技术商业转化办公室的商业顾问。 Daniel 拥有以色列巴伊兰大学的工商管理硕士学位。

技能和专长

商业顾问

技术商业化

教育背景

MBA

Bar-Ilan University, Israel

语言

Chinese

English

Spanish

7

Li Ye

Business Development, China


About Li Ye

Senior marketing and business operations executive. With over 20 years of experience in China healthcare market, Li Ye has a proven track record in marketing and sales with Drager and Maquet. Li has an MBA from the University of Washington.

Skills and Specialties

Business Operations Executive

Business Development

Education

MBA

University of Washington

Language

Chinese

English

7

Li Ye

中国业务发展


关于Li Ye

高级营销和业务运营主管。Li Ye在中国医疗保健市场拥有超过 20 年的经验,在 Drager 和 Maquet 的市场和销售方面有着良好的业绩记录。 Li 拥有华盛顿大学的工商管理硕士学位。

技能和专长

业务运营主管

业务发展

教育背景

MBA

University of Washington

语言

Chinese

English

3

Justin Shen

Chief Financial Officer


关于 Justin

Justin 拥有经济学硕士学位,是中国注册会计师(非执业)。同时是高级会计师,从事企业财务管理逾25年。历任HK.01893财务经理、AXENT International Group投资总监。

技能和专长

高级会计师

企业财务管理

教育背景

master’s degree in economics

China CPA (non-practicing)

语言

Chinese

English

3

Justin Shen

Chief Financial Officer


About Justin

Justin has a master’s degree in economics and is a China CPA (non-practicing). He is a senior accountant engaged in corporate financial management for over 25 years. He has successively served as financial manager of HK.01893 and investment director of AXENT International Group.

Skills and Specialties

senior accountant

corporate financial management

Education

master’s degree in economics

China CPA (non-practicing)

Language

Chinese

English

9

Phoenix Zhou

医学专家


关于Phoenix

Phoenix 在香港大学获得医学博士学位, 主攻心血管影像专业,现任职于浙江中医药大学邵逸夫医院。 Phoenix 还是牛津大学的博士候选人。

技能和专长

医学专家

心血管影像专业

教育背景

MD

University of Hong Kong

Ph.D. Candidate

Oxford University

语言

Chinese

English

9

Phoenix Zhou

Medical Expert


About Phoenix

Phoenix obtained his MD degree from the University of Hong Kong. Specializing in Cardiovascular Imaging, Dr. Zhou is now working for Sir Run Run Shaw hospital, Zhejiang Chinese University of Medicine. Phoenix is a Ph.D. Candidate at Oxford.

Skills and Specialties

Medical Expert

Specializing in Cardiovascular Imaging

Education

MD

University of Hong Kong

Ph.D. Candidate

Oxford University

Language

Chinese

English

8

Young Zhang

GM, Marketing & Sales, China


About Young

Young Zhang is an expert in marketing and sales within the healthcare industry, with over ten years of experience in the Chinese medical device market. He has been instrumental in helping Televia establish itself in the Chinese market, working with prestigious brands such as Siemens, Carestream, Teledynamics, and Medistim. Young is skilled in developing marketing plans and achieving sales goals with his team.

Skills and Specialties

Marketing and Sales

Education

Bechelor of Biomedical Engineering

Fujian Normal University

Language

Chinese

English

8

Young Zhang

中国市场营销总经理


关于Young

Young Zhang 是医疗保健行业的市场营销专家,在中国医疗器械市场拥有超过十年的经验。他与Siemens、Carestream、Teledynamics 和 Medistim 等知名品牌合作,帮助 Televia 在中国市场站稳脚跟。 Young 善于制定营销计划并与他的团队一起实现销售目标。

技能和专长


<h4市场和销售

教育背景

Bechelor of Biomedical Engineering

Fujian Normal University

语言

Chinese

English

11

Michael Tung

Strategy, Global


About Michael

Mr. Michael Tung is a veteran private equity professional specializing in growth capital, buyout, mergers, restructuring, and other alternative investment transactions with a wealth of investment experience in the Greater China and global media and retail sectors. He was the Chief Investment Officer of CMC from July 2008 to July 2011. Before being invited to oversee CMC’s investment activities, Mr. Tung founded M Square Capital Partners in January 2008. Before founding MSCP, Mr. Tung was a partner at Sycamore Ventures from 2001 to 2007, where he was responsible for Sycamore’s investment activities in Greater China. Sycamore Ventures was spun-off from Citigroup Venture Capital (CVC) in 1995. CVC, formed in the 1970s, is one of the earliest US-based PE fund management companies and remains a shareholder of Sycamore Asia and the largest limited partner of Sycamore’s funds. Before joining Sycamore Ventures, Mr. Tung worked at Merrill Lynch New York’s Global Debt Group, specializing in structured finance products such as Asset-Backed Securities, Collateralized Mortgage Obligations, Collateralized Bond Obligations, and CMBS. Mr. Tung began his career working in the Portfolio Management Unit at MetLife, where he analyzed credit exposure, risk, and returns of several fixed-income portfolios.

Mr. Tung is Vice Chairman of Arrow Medsource Group (“AMG”) and Chief Strategic Officer of UC Global (“UCG”). AMG is the exclusive supply chain solutions partner in Pan-Asia for one of the world’s largest GPO (Group Purchasing Organization) and healthcare improvement tech companies. And UCG is a lifestyle company focusing on alternative festivals and special events in Asia with brands such as Ultra, a leading multistage electronic dance music festival, and Wanderlust, one of the most influential yoga festivals.

Mr. Tung previously served as Chairman of Sakura (China) Co., Ltd., one of China’s largest branded kitchen appliance manufacturers. Mr. Tung was the lead arranger in the acquisition of Shaw Brothers by a consortium led by Dr. Charles Chan in 2011, whereby the consortium, via the transaction, became the single largest shareholder of Hong Kong-based Television Broadcasts Ltd. Mr. Tung also was the lead executor of CMC’s purchase of a controlling stake in CMC-News Asia Holdings (aka Star China Media), which compose certain of News Corporation’s Asian assets, in 2010.

Mr. Tung graduated from Syracuse University, majoring in Finance.

Skills and Specialties

Chief Investment Officer

Education

Majoring in Finance

Syracuse University

Language

Chinese

English

11

Michael Tung

全球战略


About Michael

董先生在私募股权投资领域从业多年,擅长成长性资本、收购、合并、重组等类型的交易。并且对中国及海外的媒体、零售等行业有着丰富的投资经验。2008年7月至2011年7月,董先生应邀成为华人文化(天津)投资管理有限公司(以下简称“CMC管理公司”)的首席投资长。在被邀请加入CMC管理公司之前,董先生曾于2008年1月创立了M Square Capital Partners Limited(“MSCP”)。2001年至2007年董先生曾任梧桐投资(Sycamore Ventures)合伙人,负责梧桐投资在中国的业务,梧桐投资是从花旗风险投资部(CVC)分拆出来的独立公司,成立于1995年。CVC是成立于70年代的最早一批私募股权基金管理公司之一,是梧桐投资亚洲公司的股东以及旗下基金的最大有限合伙人。加入梧桐投资之前,董先生就职于美林证券总部的全球债券部门(Merrill Lynch Global Debt Group),负责结构融资产品,包括各类型资产证券化(ABS),抵押贷款担保债券(CMO),资产抵押债券(CBO)以及商业抵押贷款债券(CMBS)。加入美林证券之前,董先生曾在大都会保险公司(MetLife)投资部负责分析多种固定收益产品的信用结构、风险及回报率。

董先生目前还担任Arrow Medsource Group(以下简称“AMG”)的副董事长及UC Global(以下简称“UCG”)的首席策略长。AMG的合作伙伴是全球最大的GPO(医疗集体采购组织)和医疗提效科技公司之一,AMG是其在泛亚地区的独家供应链解决方案合作伙伴。UCG是一家专注于亚洲另类节事的公司,旗下品牌包括Ultra——领先的多舞台电子音乐节,以及Wanderlust——全球最具影响力的瑜伽生活节之一。

董先生也曾担任樱花卫厨(中国)有限公司的董事长,樱花卫厨(中国)有限公司是中国最大的卫厨产品生产商之一。2011年,董先生是以陈国强为首的收购团队成功收购邵氏兄弟并间接成为TVB大股东一案的主要交易Arranger;董先生是2010年CMC收购默多克旗下新闻集团亚洲星空业务的主要执行者。

董先生毕业于雪城大学(Syracuse University),主修金融。

技能和专长

首席投资官

教育背景

Majoring in Finance

Syracuse University

语言

Chinese

English

13

Mounang Desai

Healthcare Insights, USA


About Mounang

Mounang is an MD, FACEP, and an executive-level healthcare & operations management professional with over two decades of experience; He was previously a member of a group of forward-thinking physicians who developed and owned one of the most successful acute-care hospitals in the US. Currently, Mounang is the President of Cypress Emergency Associates (CEA). He has an MBA from the University of Chicago Booth School of Business.

Skills and Specialties

President of Cypress Emergency Associates (CEA)

healthcare & operation management

Education

MBA

University of Chicago Booth School of Business

Language

English

13

Mounang Desai

美国医疗保健行业顾问


关于Mounang

Mounang 是一名医学博士、美国急诊医师学会会员,以及一名拥有超过二十年经验的医疗保健和运营管理专家;他曾是一个具有前瞻性思维的医生团队成员,该团队开发并拥有了美国最成功的急性护理医院之一。目前,Mounang 是 Cypress Emergency Associates (CEA) 的总裁。他拥有芝加哥大学布斯商学院的工商管理硕士学位。

Skills and Specialties

President of Cypress Emergency Associates (CEA)

健康与运营管理

教育背景

MBA

University of Chicago Booth School of Business

语言

English

2-ch

Olga Yanovskaya

全球总裁


关于 Olga

Olga 是医疗器械全球渠道管理方面的专家,专注于发达市场和新兴市场。她曾与欧洲、中东和非洲、拉丁美洲和亚太地区的顶级公司合作。她拥有 Universitat Pompeu Fabra 的医疗保健经济学硕士学位和 IE 商学院的 MBA 学位。 Olga 深谙工作和生活,精通多种语言。

技能和专长

全球渠道管理

新兴市场

教育背景

master’s degree in Healthcare Economics

Universitat Pompeu Fabra

MBA

IE Business School

语言

Chinese

English

Spanish

2

Olga Yanovskaya

President, Global


About Olga

Olga is an expert in global channel management for medical devices, focusing on developed and emerging markets. She has worked with top EMEA, Latin America, and APAC companies. She has a master’s degree in Healthcare Economics from Universitat Pompeu Fabra and an MBA from IE Business School. Olga is well-versed in her work and life experiences and is proficient in multiple languages.

Skills and Specialties

global channel management

emerging markets

Education

master’s degree in Healthcare Economics

Universitat Pompeu Fabra

MBA

IE Business School

Language

Chinese

English

Spanish